๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Biochemotherapy for advanced melanoma

โœ Scribed by Ulrich Keilholz; Martin E. Gore

Book ID
114481267
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
72 KB
Volume
29
Category
Article
ISSN
0093-7754

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Biochemotherapy for melanoma
Biochemotherapy for melanoma
โœ Philip Agop Philip; Lawrence E. Flaherty ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Current Science Inc. ๐ŸŒ English โš– 393 KB
Pilot study of high-dose, concurrent bio
Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma
โœ Kevin B. Kim; Omar Eton; Mary Jo East; Cynthia Hodges; Nicholas E. Papadopoulos; ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB

## Background: Durable complete response rates ranging from 5% to 20% have been reported in association with biochemotherapy for patients with metastatic melanoma, with response rates on the low end of this range being observed in trials that used lower doses and less intense treatment schedules. i

Biochemotherapy of melanoma
Biochemotherapy of melanoma
โœ Lawrence E Flaherty; Shirish M Gadgeel ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 92 KB
Biochemotherapy in patients with advance
Biochemotherapy in patients with advanced head and neck mucosal melanoma
โœ Holly L. Bartell; Agop Y. Bedikian; Nicholas E. Papadopoulos; Tina K. Dett; Matt ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 1 views

## Abstract ## Background. No systemic therapy regimen has been recognized as effective for metastatic mucosal melanoma of the head and neck. We retrospectively analyzed the effectiveness of biochemotherapy in patients with advanced head and neck mucosal melanoma. ## Methods. We evaluated the me

Biochemotherapy for melanoma : Rational
Biochemotherapy for melanoma : Rational therapeutics in the search for weapons of melanoma destruction
โœ Kim A. Margolin ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB

Understanding of the mechanisms underlying the activity and limitations of biochemotherapy remains inadequate. The design of new regimens should based on emerging knowledge regarding molecular mechanisms of oncogenesis, cancer cell proliferation and survival, and control apoptosis. See also pages 5